EGFR and neoplasm: Dysregulation of the EGFR signaling pathway through LLPS-mediated mechanisms can lead to the upregulation of transcription factors, such as c-Myc, and COX-2, promoting tumor growth, invasion, and angiogenesis [25, 39].